FastWave Medical Achieves Seventh Patent for Advanced Laser IVL Technology
Summary
FastWaves rapidly growing intellectual property portfolio underscores the companys impressive development efforts. "This milestone reflects the incredible talent of our entire team and our dedication to equipping physicians with cutting-edge tools for their most challenging cases," said Scott Nelson, co-founder and CEO of FastWave Medical. FastWaves COO Tristan Tieso added, "Our laser IVL technology continues to push the boundaries of whats possible in treating calcified arteries, getting us closer to our primary goal of helping interventionalists ensure the best care for their patients." FastWave Medical is at the forefront of developing advanced intravascular lithotripsy (IVL) systems for calcific artery disease. With an emphasis on empowering physicians with procedural efficiency, FastWave aspires to redefine the sector by introducing next-generation IVL technologies that elevate the clinician experience and overall patient care.